Spanberger launches 2020 Prescription Drug Survey
Abigail Spanberger has launched her 2020 Prescription Drug Survey to gather direct feedback from her constituents on the growing crisis of prescription drug costs.
Since taking office last year, Rep. Spanberger, D-Va., has worked on multiple pieces of legislation aimed at reducing the high cost of prescription drugs for Central Virginia families, seniors, and those with chronic conditions.
Her efforts include leading the bipartisan Public Disclosure of Drug Discounts Act, which passed 403 to 0 in the U.S. House, and passing the Lower Drug Costs Now Act, which would empower Medicare Part D to negotiate and fight for lower drug prices for beneficiaries.
“Across our ten counties, constituents of all ages come up to me and raise their concerns about the rising cost of prescription drugs. They’ve shared stories about rationing doses and making trade-offs with other expenses like groceries in order to afford their medication. This affordability crisis creates intense anxiety for so many members of our Central Virginia communities, and meaningful, bipartisan action in the House is long overdue,” said Spanberger.
“Listening to the people I serve is a critical component of any legislative effort. As I continue to work on this issue in Washington, I want to hear more facts and experiences from Central Virginians. This firsthand input will help me better address our district’s concerns and build consensus among lawmakers on both sides of the aisle. I encourage Central Virginians to complete the three-minute survey, and I thank everyone for sharing their perspective. I look forward to reading the results.”
Throughout months of legislative work, Spanberger has regularly invited constituents in the Seventh District to share their stories and give direct input on the issue.
In August, she convened a prescription drug roundtable in Henrico to hear from patients and discuss potential legislative solutions.